Stephanie Christenson, MD MAS

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    GlaxoSmithKline
    Topic:
    COPD
    Date added:
    03/04/2026
    Date updated:
    03/04/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Verona Pharma
    Topic:
    COPD
    Date added:
    03/04/2026
    Date updated:
    03/04/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Amgen
    Topic:
    COPD
    Date added:
    03/04/2026
    Date updated:
    03/04/2026
    Relationship end date:
    05/31/2025
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Devpro Biopharma/Uniquity Bio
    Topic:
    Asthma/COPD
    Date added:
    03/04/2026
    Date updated:
    03/04/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Kymera Therapeutics
    Topic:
    Asthma
    Date added:
    03/04/2026
    Date updated:
    03/04/2026
    Relationship end date:
    08/01/2024
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Gilead
    Topic:
    Asthma/COPD
    Date added:
    03/04/2026
    Date updated:
    03/04/2026
    Relationship end date:
    10/30/2025

Pages

Return to 2026 California Thoracic Society Annual Educational Conference & Chronic Obstructive Pulmonary Disease Symposium